Fenosa®

Regorafenib

Product Information

  • Proprietary Name: Fenosa®
  • Generic Name: Regorafenib
  • Dosage Form: Film-coated Tablet
  • Strengths: 40 mg
  • Indications: Colorectal Cancer, Gastrointestinal Stromal Tumors, Hepatocellular Carcinoma

Oncology

Fenosa®

Regorafenib is indicated for the treatment of colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma.

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.